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   EXPERIMENTAL SOLUBILITY 
MEASUREMENT OF CEPHALEXIN IN 
SUPERCRITICAL CARBON DIOXIDE 
Article Highlights 
•  Solubility of cephalexin in supercritical carbon dioxide was measured in wide range of 
temperature and pressure 
•  Solubility of cephalexin was in range of 1.13×10
–5 to 4.89×10
–3 based on mole fraction 
•  Obtained solubilities were correlated using four different semi-empirical correlations 
 
Abstract 
In recent years, the use of supercritical carbon dioxide for different chemical 
processes, in particular particle micronization, has surprisingly increased. 
Knowing the substance solubility in supercritical solvent is a critical parameter 
during the particle size reduction processes. In this direction, solubility of ceph-
alexin was measured in the supercritical carbon dioxide by changing the tem-
perature and pressure between 308.15 and 338.15 K and from 16 to 40 MPa, 
respectively. The measured solubility of cephalexin in supercritical carbon 
dioxide was in the range of 1.13×10
–5 to 4.89×10
–3 based on the mole fraction 
at the different operational condition. Besides the experimentally measurement 
of cephalexin solubility, modeling of the results using four commonly used cor-
relations, namely Mendez-Santiago and Teja (MST), Bartle, Kumar and 
Johnston and Chrastil models were utilized. The results revealed that the 
Chrastil model was the most accurate used semi-empirical correlation in the 
present study with the lowest average absolute relative deviation percent of 
(AARD) of 9.43%. 
Keywords: solubility, cephalexin, supercritical carbon dioxide, semi-empi-
rical correlation. 
 
 
Using conventional pharmaceutical techniques 
such as emulsification and solvent evaporation intro-
duces several disadvantages; in particular, the rem-
aining residual organic solvent in the product reduces 
the final product quality [1]. The increasing health 
concerns about the presence of solvents such as 
methylene chloride in the products motivate the inves-
tigators and scientists to direct their research to find-
ing replacements that are “environmentally benign” for 
the conventional solvents. In other words, the res-
earchers around the world are trying to find a new 
kind of solvent which are green and highly efficient [2]. 
                                                 
Correspondence: A.Z. Hezave, Islamic Azad University, Dash-
testan Branch, P.O. Box: 71346-1719, Borazjan, Iran. 
E-mail: ali_zeinolabedini@yahoo.com 
Paper received: 28 November, 2012 
Paper revised: 12 May, 2013 
Paper accepted: 17 June, 2013 
So, over the last thirty years, research has 
focused on supercritical carbon fluids (SCFs), espe-
cially carbon dioxide, as a replacement for the con-
ventional solvents. The mild critical conditions of tem-
perature and pressure of carbon dioxide (CO2) com-
pared with several other possible solvents makes it a 
good candidate for the supercritical based-technol-
ogies [3-6]. Generally, supercritical carbon dioxide 
(SC-CO2)-based technologies seem efficient for the 
drug processing considering the aforementioned dis-
advantages of traditional pharmaceutical industries 
accompanied with the advantages of the SC-CO2. 
Among the different applications of the SC-CO2, 
the precipitation of drug particles using supercritical 
and near SC-CO2 both as a solvent and anti-solvent 
has been increasingly investigated, since it can be 
industrialized [7-12]. Common SC-CO2 based-tech-
nologies for particle engineering are rapid expansion 
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(GAS), precipitation by compressed anti-solvent 
(PCA), etc. [13,14].  
It should be highlighted that the crucial para-
meter that must be known during the equipment siz-
ing is the solubility (one of the most important phase 
behavior parameters) of a compound in the SC-CO2, 
to enable the designer to select the best pharmaceut-
ical processing method and operational conditions. 
Often, the solubility of substances is a limiting factor 
during the particle size engineering processes [15]. In 
this regard, many research groups around the world 
have measured and reported solubility of different 
substances in SC-CO2 at different temperatures and 
pressures and at the presence and absence of co-
solvents [16-24]. 
However, experimental measurement is not 
always a feasible tool, i.e., due to a wide range of 
operational conditions including pressure and tempe-
rature and many possible substances, it is expensive 
and in some cases impossible to experimentally mea-
sure the equilibrium solubility of substances in the 
SCF. Thus, apart from the measurements of the solu-
bility of substances, researchers have been focused 
on proposing accurate and simple correlations and 
models to correlate/estimate the solubilities of solids 
such as the pharmaceutical compounds in CO2 
[25-37]. 
The two most widely used methods for correl-
ating the solubilities of solid substances in SC-CO2 
are equations of state (EoSs) and semi-empirical cor-
relations. In some cases, using EoSs is not recom-
mended since these methods needs several pro-
perties such as critical pressure and temperature, 
acentric factor, etc., that cannot be easily measured 
experimentally. Therefore, it would be necessary to 
use the predicted/estimated parameters, introducing 
errors into the obtained predicted solubilities.  
Based on these facts, cephalexin solubility in 
SC-CO2 was measured using a simple gravimetric 
method coupled with static method. To the best of our 
knowledge, no reported experimental data on the 
cephalexin solubility is reported. Since there are 
limited reports on the solubility on the active pharma-
ceutical ingredients (APIs) in the SCF [14], it seems 
applicable to measure the cephalexin solubility in the 
SC-CO2 in a different temperatures and pressures. 
Cephalexin (also called Cefalexin), an active 
pharmaceutical ingredient drug (API drug), is a semi-
synthetic cephalosporin antibiotic intended for oral 
administration with the molecular formula of 
C16H17N3O4S and molecular weight of 347.41 g/mol. 
Cephalexin, which is commonly found in monohydrate 
form, introduces a low water solubility of about 1 or 2 
mg/mL. Cephalexin is commonly prescribed to cure 
different disease and disorders such as urinary tract 
infections, respiratory tract infections, and skin and 
soft tissue infections. Generally, due to a vast range 
of application, cephalexin is one of the most pres-
cribed antibiotics around the world.  
EXPERIMENTAL 
Material 
Cephalexin supplied by Alma Concept Company 
(France) was used as a model drug without any 
further purification as received. Before the main 
experiments, cephalexin was exposed to SC-CO2 
under the pressure and temperature of 40 Mpa and 
308.15 K, respectively, for 3 h. Also, carbon dioxide 
(99.8% purity) was kindly supplied by Abughadareh 
Industrial Gas Company (Iran) was used as a solvent 
for all the measurements. Before and after each 
experiment, the cephalexin powder was heated up to 
318.15 K in an oven (Behdad, Iran) overnight to 
ensure no presence of carbon dioxide in the sample. 
Laboratory apparatus 
In this investigation, a home-made apparatus 
rated for pressures of 60 MPa at 673 K equipped with 
a sapphire window was used to measure the solubility 
of model drug using a static method coupled with a 
gravimetric method [23,24,33-36]. The used appa-
ratus in this study was the modified form of its last 
version used in the previous works [33]. The volume 
of the modified equilibrium cell was increased so that 
it could handle a larger amount of carbon dioxide. As 
a result, the capability of supercritical carbon dioxide 
to dissolve the model drug was increased, which led 
to reduction of the error of weighing the sample. 
In other words, a higher volume of supercritical 
carbon dioxide at the desired pressure and tempe-
rature means a higher amount of solubilized solid, 
which enhances the accuracy of weighing the sample. 
In this regard, the volume of the equilibrium cell was 
enhanced to 50 cm
3. The used procedure of the mea-
surements in this study was as follows: CO2 was filled 
into the upper section of a displacer. The lower sec-
tion of the displacer was filled by fresh water pres-
surized  via a reciprocating manual pump (Haskel 
Pump, Burbank, USA). The pressure of displacer was 
indicated by a pressure gauge ranged up to 45 MPa 
in increments of 0.1 MPa (DEWIT).  
After pressurizing to the desired value, CO2 was 
allowed to flow into the homemade variable volume 
cell. The pressure of the equilibrium cell was moni-
tored using WIKA type pressure indicator in the range S.A. SHOJAEE et al.: EXPERIMENTAL SOLUBILITY MEASUREMENT…  Chem. Ind. Chem. Eng. Q. 20 (3) 387−395 (2014) 
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of 0–40 MPa with precision of 0.01 MPa. A PT-100 
resistance thermometer with precision of 1 K was 
used to control the temperature of the system at 
desire value using a PID controlling method. Also, the 
system pressure was maintained constant within 
±0.5% of the desired value throughout the experi-
ment. For each experiment, 1 g of pure model drug 
powder was compacted (with no additives) in a com-
pactor instrument (Compactor, T555228, Mellat 
Mashin Sazi Company, Iran) under a pressure of 2 
MPa, to change the powder into a 5 mm diameter 
tablet. After charging the sample into the equilibrium 
cell, the piston inside the cell was moved forward in 
order to reduce the available volume as much as 
possible. After that, the carbon dioxide was allowed to 
pass through the equilibrium cell while the outlet valve 
was open. After a few seconds, the outlet valve was 
closed, and the piston inside the equilibrium cell was 
moved backward to increase the volume to its maxi-
mum value of 50 cm
3. Then, the system was pres-
surized to the desired value. This step was done to 
discharge the air from the equilibrium cell, which 
might affect the composition of supercritical carbon 
dioxide. During the experiments, compacted drug 
powder was held at constant desired pressure and 
temperature in contact with SC-CO2 for about 2.5–3 h 
and the equilibrium cell was shaken in order to ensure 
the attainment of equilibrium. Finally, the equilibrium 
cell was suddenly depressurized to the ambient con-
ditions and the remaining drug was weighed to 0.1 
mg using a Sartorius BA110S Basic series balance. 
The potential error due to weighing was 2 wt.% since 
the typical mass of solute for each experiment was 
greater than 5 mg. now by dividing the difference 
between the initial and final weight of solute the mole 
value of solubilized drug calculated. Then, the weight 
of used carbon dioxide in each experiment was 
obtained by using the density of carbon dioxide at the 
specific temperature and pressure reported by Yamini 
et al. [18], while the used volume of carbon dioxide for 
all the experiments was 50 cm
3. 
Similar to the previous stage, by dividing the 
weight of carbon dioxide to its molar mass, the used 
mole of carbon dioxide in each experiment calculated. 
Finally, the solubility of cephalexin calculated as: 
=
moles of cephalexin
moles of cephalexin+moles of carbondioixide
y  (1) 
RESULTS AND DISSCUSION 
The cephalexin solubility was measured at 
seven pressure values (16, 20, 24, 28, 32, 36 and 40 
MPa) and four temperatures (308.15, 318.15, 328.15 
and 338.15 K). For each data point, at least three 
independent measurements were performed and then 
the average of those measurements was reported as 
the solubility of that point. In addition, the statistical 
and error analysis revealed that measurements intro-
duce a maximum percent relative standard deviation 
of ±7.5% during the solubility measurements.  
In statistics, the value of the coefficient of the 
variation is generally called the relative standard devi-
ation. The relative standard deviation has its own 
importance in the field of science and plays a vital 
role in the calculation and measurement process. In 
general, standard deviation is a measure of how pre-
cise the average is, that is, how well the individual 
numbers agree with each other. In total, lower relative 
standard deviation means higher repeatability cap-
ability of the measurements. Relative standard devi-
ation is calculated by dividing the standard deviation 
of values by the average of the values (Eq. (2)): 
=
×
=
Relative standard deviation ( )
100 Standard deviation 
 
Average of solublity at each point
RSD
 (2) 
It must be noted that the accuracy of the used 
method (along to the application of pellet instead of 
drug powder) was previously examined by measuring 
the solubility of piroxicam (Table 1) [33]. Although the 
measured solubilities revealed a systematic  lower 
measured solubility of piroxicam, the general average 
absolute relative deviation of 6.28% showed a rather 
good accuracy of the used method. So, it seems that 
although there is no direct mixing in the equilibrium 
cell, shaking of the system can compensate to some 
extent the shortage of direct mixing. In other words, 
due to no direct mixing of equilibrium cell content, it is 
possible to measure lower solubility than its real 
Table 1. Comparison of the obtained solubilities of piroxicam with solubilities reported in other literature (mol solute/10
5 mol CO2) [37] ; 
temperature: 312.5 K 
Pressure /MPa  Literature   This work 
10 1.30  1.21 
13 2.08  1.92 
16 3.12  2.92 
19 4.41  4.23 S.A. SHOJAEE et al.: EXPERIMENTAL SOLUBILITY MEASUREMENT…  Chem. Ind. Chem. Eng. Q. 20 (3) 387−395 (2014) 
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value. However, the prior examinations revealed that 
this method and settling time can lead to rather accu-
rate measurments of the solubility.  
In more details, the used procedure was vali-
dated in the previous work with a typical AARD error 
lower than 7% [33]. Also, using this established, 
validated and published method solubility of other 
pharmaceuticals including ceterizine [24], diclofenac 
acid [33], phenylephrine hydrochloride [36], sulindac 
[35], fluoxetine hydrochloride [34], mefenamic acid 
[23] were successfully measured. 
The measured solubility data points of cephal-
exin have been reported in Table 2. Considering the 
solubility trend variation, one can find that cephalexin 
solubility shows a direct relation to pressure while a 
slightly more complex effect was obtained for tempe-
rature. 
 
The obtained pressure pattern can be contri-
buted to the phenomenon that the carbon dioxide 
pressure increases when the pressure enhances. 
Besides, the pressure enhancement decreases the 
mean distance between the CO2 and solute mole-
cules increases the specific interaction between the 
model drug and supercritical fluid molecules [38]. 
However, temperature introduces different effects, 
including variation of solute vapor pressure, density of 
SC-CO2 and the interaction between the molecules in 
the fluid phase.  
The obtained results revealed that when the 
pressures are below the crossover pressure (for the 
cephalexin 16–18 MPa), solvent densities significantly 
reduce as the temperature increases. However, 
above the crossover pressure, the solvent density is 
more independent of temperature, in which the solu-
bility increases under the effect of higher solid vapor 
Table 2. The solubility of the cephalexin (mol solute/10
5 mol CO2) at different pressures and temperatures based on the mole fraction; 
Overall relative standard deviation: 7.5% 
Pressure, MPa  Solubility  Standard deviation  Relative standard deviation, % 
T = 308.15 K 
16 1.68  0.126  7.5 
20 2.21  0.135  6.1 
24 3.98  0.221  5.6 
28 6.89  0.345  5.0 
32 11.3  0.520  4.6 
36 15.4  0.698  4.5 
40 20.8  0.984  4.7 
T = 318.15 K 
16 1.42  0.108  7.5 
20 3.87  0.169  4.4 
24 9.31  0.365  3.9 
28 18.7  0.875  4.7 
32 36.5  0.112  3.1 
36 52.3  0.387  7.4 
40 73.2  0.552  7.5 
T = 328.15 K 
16 1.13  0.0850  7.5 
20 5.21  0.312  6.0 
24 1.76  0.124  7.0 
28 41.1  2.89  7.0 
32 74.5  4.58  6.1 
36 131  9.89  7.5 
40 179  11.9  6.6 
T = 338.15 K 
16 –  –  – 
20 5.54  0.235  4.2 
24 25.4  0.987  3.9 
28 72.1  4.25  5.9 
32 154  8.88  5.8 
36 301  10.3  3.4 
40 489  22.2  4.5 S.A. SHOJAEE et al.: EXPERIMENTAL SOLUBILITY MEASUREMENT…  Chem. Ind. Chem. Eng. Q. 20 (3) 387−395 (2014) 
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pressure [38]. But, plotting the measured solubility 
data as a function of density, it is completely obvious 
that the crossover effect that has been observed in 
Figure 1 (solubility vs. pressure plot) is a density 
effect. In other words, if pressure replaced by density 
(see Figure 2), the solubility isotherms no longer 
cross each other. So, it can be concluded that within 
the pressure region investigated, there is still a mono-
tonous increase of solubility. In addition, Foster et al. 
[39] reported that the reliability and consistency of 
experimental solubility data can be examined by the 
existence of a crossover pressure in solid-SCF 
systems. 
 
Figure 1. Experimentally measured solubility of cephalexin in 
wide range of temperature and pressure (isotherms: o – 308.15, 
□ – 318.15, × – 328.15 and • – 338.15 K). 
In the second stage of this investigation, four 
different correlations were applied to model the 
obtained solubility data measured experimentally in 
this study (Table 3).  
Table 3. The obtained fitting constants for four density based 
correlations 
Model 
Constants 
a b  c 
Bartle [28]  52.710  -19216.00 0.026
Mendez-Santiago-Teja [27]  27123-  58.04  8.745
Kumar and Johnston [30]  26.35  -17368  0.979
Chrastil [29]  -17362  -74.70  19.110 
For the first stage of the modeling, the solubility 
of cephalexin was correlated using MST model as the 
functions of temperature, pressure and density of 
supercritical fluid. The general form of the MST model 
(Eq. (3)) comprises of three adjustable parameters, 
which were calculated using a simple linear 
regression: 
ρ
− 
=+ + 

1- 1 3 - 3
ref ln (K ) (K) (kg m ) (kg m )
yp
Ta b T c
p
 (3) 
The regression results revealed a high capability 
of the MST model to accurately model the cephalexin 
solubility with an AARD of 11.5%. In addition, the ext-
rapolative capability of the MST model was examined 
by a self-consistency test. The result of this test 
(Figure 3) not only shows a linear behavior of cepha-
lexin solubility illustrated consistent measured solid 
solubility data at all experimental conditions, but also 
can be used to extrapolate the solubility of cepha-
lexin. 
 
Figure 2. Solubility of gabapentin as a function of density (isotherms: o – 308.15, □ – 318.15, × –  328.15 and • - 338.15 K). S.A. SHOJAEE et al.: EXPERIMENTAL SOLUBILITY MEASUREMENT…  Chem. Ind. Chem. Eng. Q. 20 (3) 387−395 (2014) 
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Figure 3. The self-consistency test of the measured cephalexin 
solubility using MST model (isotherms: o – 308.15, □ – 318.15, 
× –  328.15 and • - 338.15 K). 
In the second stage, the measured cephalexin 
solubility was correlated by the Bartle et al. model 
[28]:  
ρρ
− 
=+ + − 

13 2
ref ref
(K)
ln (kg m )( )
(K)
yp b
ac
T p
 (4) 
where a, b and c are fitting parameters, y is the solute 
solubility and ρ is the density of carbon dioxide at a 
specific pressure and temperature modified by sub-
tracting 700 kg m
–3 considering as the reference den-
sity, ρref. 
In this regard, using the least-squares regres-
sion method and plotting ln(yp/p
ref) against density, 
leads to a straight line which parameter of c can be 
easily obtained from it. Theoretically in this stage, 
according to the Bartle et al. model [28] one expects 
to observe straight lines with similar slopes through 
the plots. But, the scattering nature of the experi-
mental measurements leads to different slopes makes 
to use average of these slope values for the rest of 
modeling procedure. Then, by using the average 
value of c and solubility data values of a and b for the 
Bartle et al. model can be obtained by another data 
regression [28]. The obtained results graphically 
demonstrated in Figure 4 revealed that using the 
Bartle et al. model leads to an AARD of 10.7%.  
It should be mentioned is that the fitting para-
meter of b in the Bartle et al. model is a parameter 
that one can roughly obtain heat of sublimation using 
the following equation [40]: 
Δ= − sub   HR b  (5) 
where  R  is the gas universal constant. Finally, the 
measured solubility of cephalexin was correlated with 
the aid of two other semi-empirical correlations of 
Chrastil [29] and KJ [30].  
The Chrastil correlation was based on this 
assumption that the solute molecules surrounded by c 
molecules of a solvent form a solute-solvent complex. 
In other words, in the Chrastil model (Eq. (6)), the 
fitting parameter c indicates the number of solvent 
molecules surrounding the solute molecule: 
 
Figure 4. Correlated cephalexin solubility using Bartle et al. [28] model (isotherms: o – 308.15, □ – 318.15, × –  328.15 and • - 338.15 K).S.A. SHOJAEE et al.: EXPERIMENTAL SOLUBILITY MEASUREMENT…  Chem. Ind. Chem. Eng. Q. 20 (3) 387−395 (2014) 
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ρ =+ + ln   () / () ln Sa b K T Kc  (6) 
where a, b and c are the fitting parameters and S is 
the solute solubility in kg m
–3. The b parameter can be 
utilized to estimate the solute heat of sublimation (ΔH 
sub = –Rb). 
Also, the K-J model proposed in 1988 (see Eq. 
(7)) is:  
ρ =+ +
3- 1 - 3 ln (K) / (K) (m kmol ) (m kmol) ya b T c  (7) 
The fitting parameters of this correlation can be 
easily obtained by a simple data regression. In 
details, in the first step, the logarithm of the solute 
solubility data was plotted versus density of carbon 
dioxide in for all isotherms. Then, the slopes of the 
curves were calculated by a passing a linear curve. 
The average of each slope was used for the rest of 
calculations. In other words, by plotting ln y – caverageρ 
against  T
–1,  a and b can be obtained and now it is 
possible to correlate the solubility of cephalexin 
(Table 3). 
In total, similar to the previous sections, using a 
simple curve fitting leads to find the fitting parameters 
of these two correlations reported in the Table 3. In 
addition, for better representation, the obtained results 
for the K-J model shown in Figure 5 revealed a rather 
good agreement between the experimental and cor-
related solubilities. The obtained results revealed that 
the Chrastil and K-J models leads to AARD of 9.43 
and 10.8%, respectively which Chrastil model leads to 
the lowest AARD among the examined correlation in 
this study.  
We finally note that although a rather good cor-
relative capability of used semi-empirical models are 
observed, the self-consistency test results (Figure 4) 
revealed a deviation from the linear behavior of in 
these correlations. This observed deviation can pos-
sibly relate to the fact that at the higher pressures 
which the density of the of compressed carbon diox-
ide amounts to a value of 972.3 kg m
–3, which is not 
so far away from water at ambient conditions, can 
lead to a phenomenon called “squeezing out”. In 
other words, at higher pressure and liquid-like den-
sities, the effect of “squeezing out”, that is a retro-
grade solubility, can often be observed leads to this 
fact that the density-based models do no longer work 
willingly in that regions. This phenomenon was 
reported by Kurnik and Reid [41] while further similar 
behavior was observed by Kraska et al. [42] for 
β-carotene solubility. They have described this obs-
erved trend based on this fact that the deviation of the 
experimental data at pressures above 125 MPa can 
be due to a special isomerization occurred by an 
enrichment of cis-isomers in the solution while the all-
trans β-carotene is squeezed out of the solution and 
crystallizes. 
CONCLUSIONS 
Solubility of cephalexin in supercritical carbon 
dioxide at different temperatures and pressures was 
measured experimentally using a static method 
coupled with gravimetric method. The measurements 
were applied in the temperature and pressure range 
 
Figure 5. The correlated experimental cephalexin solubility using K-J model (isotherms: o – 308.15, □ – 318.15, 
× –  328.15 and • - 338.15 K). S.A. SHOJAEE et al.: EXPERIMENTAL SOLUBILITY MEASUREMENT…  Chem. Ind. Chem. Eng. Q. 20 (3) 387−395 (2014) 
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of 308.15 to 338.15 K and 16 to 40 MPa, respectively. 
The solubility measurements revealed that the solu-
bility of the cephalexin ranged between 1.13×10
–5– 
–4.89×10
–3 (based on the mole fraction) at the different 
operational conditions. The obtained results that an 
increase in pressure increases the solubility. How-
ever, a complex behavior of temperature effect on the 
solubility was observed. In other words, the obtained 
results revealed that the cephalexin-SC-CO2 system 
shows a crossover pressure of about 16 to 18 MPa. In 
addition, the possible mechanisms were discussed in 
details. Finally, the measured solubility data were cor-
related using four semi-empirical density based cor-
relations, namely Mendez-Santiago and Teja (MST), 
Bartle, Kumar and Johnston, and Chrastil models with 
AARD of 11.5, 10.7, 10.8 and 9.43%, respectively. 
Finally, it was found that at higher temperatures, more 
deviation was observed in the solubility data corre-
lation, which was related to the phenomenon of 
“squeezing out”. 
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NAUČNI RAD 
   EKSPERIMENTALNO ODREĐIVANJE 
RASTVORLJIVOSTI CEFALEKSINA U 
SUPERKRITIČNOM UGLJEN-DIOKSIDU 
Prethodnih godina naglo je poraslo interesovanje za upotrebu superkritičnog ugljen 
dioksida u raznim hemijskim procesima koji se koriste za mikronizaciju čestica. Pozna-
vanje rastvorljivosti odgovarajuće supstance u superkritičnom rastvaraču je vrlo važno za 
procese usitnjavanja čestica. Zbog toga je ispitana rastvorljivost cefaleksina u super-
kritičnom ugljen-dioksidu pri promeni temperature od 308.15 do 338.15 K i pri promeni 
pritiska od 16 do 40 MPa. Za ove operacione uslove je izmerena rastvorljivost u opsegu od 
1,13×10
-5 do 4,89×10
-3 izražena u molskim frakcijama. Osim eksperimentalnog merenja 
rastvorljivosti cefaleksina, izvršeno je modelovanje pomoću poznatih korelacija, i to: 
Mendez-Santjago i Teja (MST), Bartle-Kumar-Džonstona i Črastila. Rezultati pokazuju da 
je  Črastilov model najtačniji semi-empirijski korelacioni model sa najmanjom srednjom 
apsolutnom relativnom devijacijom od 9,43%. 
Ključne reči: rastvorljivost, cefaleksin, superkritičan ugljen-dioksid, semi-empi-
rijska korelacija. 
 
 